Treatment related myelitis in hodgkin’s lymphoma following stem cell transplant, chemotherapy and radiation: a case report and review of the literature

By Gatcombe Heather   Lawson Josh   Phuphanich Surasak   Crocker Ian  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 293-298

Springer Publishing Company

Access to resources Recommend Favorite

Incidence and Characteristics of Childhood Hodgkin’s Lymphoma in Greece: A Nationwide Study (Greece)

By Petridou E.   Andrie E.   Dessypris N.   Dikalioti S.   Trichopoulos D.  

Cancer Causes and Control, Vol. 17, Iss. 2, 2006-03 ,pp. : 209-215

Springer Publishing Company

Access to resources Recommend Favorite

Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

By Koeppen S.   Verstappen C.   Körte R.   Scheulen M.   Strumberg D.   Postma T.   Heimans J.   Huijgens P.   Kiburg B.   Renzing-Köhler K.   Diener H.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Pralatrexate: treatment of T-cell non-Hodgkin’s lymphoma

By Parker Terri   Barbarotta Lisa   Foss Francine  

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 21-29

Future Medicine

Access to resources Recommend Favorite

Iodine 131 tositumomab in the treatment of non-Hodgkin’’s lymphoma

By Smith Stephen   Sweetenham John W  

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 255-262

Future Medicine

Access to resources Recommend Favorite